108 assets in Idiopathic Pulmonary Fibrosis

Therapeutic assets addressing Idiopathic Pulmonary Fibrosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Jin-Shui Huan-Xian Granule Idiopathic Pulmonary Fibrosis	Henan University of Traditional Chinese Medicine	N/A	D (30)
3d-cultured human placental mesenchymal stem cell-derived extracellular vesicles Idiopathic Pulmonary Fibrosis	Huan Ye	P1	NR ()
cmr316 Idiopathic Pulmonary Fibrosis	Calibr, a division of Scripps Research	P1	NR ()
Hrs-9813 Idiopathic Pulmonary Fibrosis	Guangdong Hengrui Pharmaceutical Co., Ltd	P1	NR ()
HW241045 Idiopathic Pulmonary Fibrosis	Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.	P1	NR ()
Regend007 Cell Therapy Idiopathic Pulmonary Fibrosis	Regend Therapeutics	Early P1	NR ()
sc01009 Idiopathic Pulmonary Fibrosis	Ruijin Hospital	P2	NR ()
syh2059 tablets Idiopathic Pulmonary Fibrosis	InnovStone Therapeutics Limited	P2	NR ()

Showing 101 to 108 of 108 assets

PreviousPage 3 of 3Next